Related Experiment Video
Updated: Jun 30, 2025
Real-Time Analysis of Bioenergetics in Primary Human Retinal Pigment Epithelial Cells Using High-Resolution Respirometry
Published on: February 3, 2023
RETRACTED: RSPO2-associated mitochondrial metabolism defines molecular subtypes with distinct clinical and immune
Quanzhou Peng1,2, Tianfeng Cao1,3, Xue Yang4
1Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Background:
Esophageal cancer is a highly aggressive malignancy with limited treatment options and poor prognosis. The identification of novel molecular subtypes and therapeutic targets is crucial for improving clinical outcomes.
Method:
In this study, we investigated the role of R-spondin 2 (RSPO2) in esophageal cancer and its association with mitochondrial metabolism. Using bioinformatics analysis of publicly available datasets, we identified a panel of RSPO2-related mitochondrial metabolism genes and their expression patterns in esophageal cancer. Based on these genes, we stratified esophageal cancer patients into distinct molecular subtypes with different survival rates, immune cell infiltration profiles, and drug sensitivities.
Results:
Our findings suggest that RSPO2-related mitochondrial metabolism genes may serve as potential therapeutic targets and prognostic markers for esophageal cancer. These genes play an important role in the prognosis, immune cell infiltration and drug sensitivity of esophageal cancer.
Conclusion:
The identified molecular subtypes provide valuable insights into the underlying molecular mechanisms of esophageal cancer and could guide personalized treatment strategies in the future.
Insights
Researchers identified R-spondin 2 (RSPO2)-related mitochondrial genes in esophageal cancer. These genes define molecular subtypes, impacting survival, immune infiltration, and drug sensitivity, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Esophageal cancer is an aggressive malignancy with poor prognosis and limited therapeutic options.
- Identifying novel molecular targets is critical for improving patient outcomes.
Purpose of the Study:
- To investigate the role of R-spondin 2 (RSPO2) in esophageal cancer.
- To explore the association between RSPO2 and mitochondrial metabolism in esophageal cancer.
- To identify novel molecular subtypes based on RSPO2-related mitochondrial genes.
Main Methods:
- Utilized bioinformatics analysis of public datasets.
- Identified RSPO2-related mitochondrial metabolism genes and their expression patterns.
- Stratified esophageal cancer patients into distinct molecular subtypes.
Main Results:
- RSPO2-related mitochondrial genes are associated with survival rates, immune cell infiltration, and drug sensitivity in esophageal cancer.
- Distinct molecular subtypes were identified based on these gene signatures.
- These genes play a significant role in esophageal cancer prognosis.
Conclusions:
- RSPO2-related mitochondrial metabolism genes represent potential therapeutic targets and prognostic markers for esophageal cancer.
- The identified molecular subtypes offer insights into esophageal cancer mechanisms.
- Findings may guide future personalized treatment strategies for esophageal cancer.
